Showing results (21-30 of 44) with videos related to
Sort By:
Pageof 5
Journal of Clinical Medicine|March 10, 2022
Different Kinetics of HBV-DNA and HBsAg in HCV Coinfected Patients during DAAs TherapyPiero Colombatto, Elena Palmisano, Gabriele Ricco, et al.Liver International : Official Journal of the International Association for the Study of the Liver|March 16, 2017
Long-term outcome of inactive and active, low viraemic HBeAg-negative-hepatitis B virus infection: Benign course towards HBsAg clearanceFilippo Oliveri, Lidia Surace, Daniela Cavallone, et al.Frontiers in Endocrinology|March 20, 2026
Case Report: Familial partial lipodystrophy, description of novel and ultrarare variants with distinct phenotypic spectrumSilvia Magno, Caterina Pelosini, Melania Paoli, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 12, 2022
Primary biliary cholangitis: perception and expectation of illnessAnnarosa Floreani, Michela Scaffidi, Barbara Coco, et al.Cancers|April 30, 2021
Modeling Hepatocellular Carcinoma Cells Dynamics by Serological and Imaging Biomarkers to Explain the Different Responses to Sorafenib and RegorafenibPiero Colombatto, Coskun Ozer Demirtas, Gabriele Ricco, et al.European Thyroid Journal|September 20, 2022
Yttrium-90 transarterial radioembolization for liver metastases from medullary thyroid cancerLuciana Puleo, Laura Agate, Irene Bargellini, et al.Gastroenterology|January 30, 2018
TLR7 Agonist Increases Responses of Hepatitis B Virus-Specific T Cells and Natural Killer Cells in Patients With Chronic Hepatitis B Treated With Nucleos(T)Ide AnaloguesCarolina Boni, Andrea Vecchi, Marzia Rossi, et al.Alimentary Pharmacology & Therapeutics|November 21, 2024
Development and Validation of a PIVKA-II-Based Model for HCC Risk Stratification in Patients With HCV-Related Cirrhosis Successfully Treated With DAAGian Paolo Caviglia, Piero Fariselli, Roberta D'Ambrosio, et al.Alimentary Pharmacology & Therapeutics|April 21, 2026
Baseline HDV-RNA Levels Could Stratify Clinical Risk Before, But Not After, Cirrhosis in Chronic Hepatitis D: A Multicentre European StudyAdriana Palom, Elisabetta Degasperi, Barbara Coco, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 18, 2013
Position paper of the Italian Association for the Study of the Liver (AISF): the multidisciplinary clinical approach to hepatocellular carcinoma, , , et al.Pageof 5